Cardiovascular diseases (CVDs) are the leading cause of premature death and disability in
humans and their incidence is on the rise globally. Given their substantial contribution …

Cardiovascular disease (CVD) represents the leading cause of death worldwide, and
equally affects both sexes although women develop disease at an older age than men. A …

Background: Endovascular therapy and intravenous thrombolysis with recombinant tissue
plasminogen activator are the 2 most recommended treatments for acute ischemic stroke …

Tremendous progress has been made in the treatment of ST-segment elevation myocardial
infarction (STEMI), the most severe and time-sensitive acute coronary syndrome. Primary …

Background Antiplatelet agents are widely used to prevent cardiovascular events. The risks
and benefits of antiplatelet agents may be different in people with chronic kidney disease …

Purpose Although the role of integrins has been described in a variety of diseases, these
roles seem to be distinct. To date, no study has attempted to provide links to the various …

Significant progress has been made in the development of medications to prevent
thrombosis and platelet aggregation. These drugs target specific components of the …

Heparin proteoglycans (HEP-PGs) carry standard heparin-mediated anticoagulant
properties as well as novel antiplatelet functions, a combination that may be significant for …

Background Currently, there is still a lack of an optimal treatment for no-reflow phenomenon
(NR). The aim of this simple meta-analysis was to evaluate the efficacy and safety of …

Acute ischemic stroke continues to be one of the leading causes of morbidity and mortality
worldwide. Recent advances in mechanical thrombectomy techniques combined with …